Alfentanil

  • TRADE NAMES: Alfenta (Akorn); Rapifen
  • INDICATIONS: General anesthesia, post-operative pain
  • CLASS: Analgesic; opioid, Anesthetic
  • HALF-LIFE: 83–97 minutes (adults)
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Ceritinib, Crizotinib, Dasatinib, Eluxadoline, Enzalutamide, Erythromycin, Itraconazole, Letermovir, Ranitidine, Ribociclib, Rifapentine, Ritonavir, Telithromycin, Voriconazole

PREGNANCY CATEGORY: C

Our database has 14 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.


Page last updated 09/03/2019

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top